Cargando…
LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson's Disease through Activating α-Synuclein Expression
Long intergenic noncoding RNA-p21 (lincRNA-p21) has been reported to be increased in Parkinson's disease (PD). However, the function and underlying mechanisms of lincRNA-p21 remain not clear. In order to explore the role of lincRNA-p21 in PD, we used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine...
Autores principales: | Xu, Xiaonan, Zhuang, Chengle, Wu, Zimu, Qiu, Hongyan, Feng, Haixia, Wu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323514/ https://www.ncbi.nlm.nih.gov/pubmed/30671473 http://dx.doi.org/10.1155/2018/8181374 |
Ejemplares similares
-
LincRNA-p21: Implications in Human Diseases
por: Tang, Sai-Sai, et al.
Publicado: (2015) -
Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21
por: Zhu, Dezhang, et al.
Publicado: (2021) -
LincRNA-p21 acts as a mediator of ING1b-induced apoptosis
por: Tran, U M, et al.
Publicado: (2015) -
Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
por: Çekin, Nilgün, et al.
Publicado: (2018) -
Up-Regulated Expression of Pro-Apoptotic Long Noncoding RNA lincRNA-p21 with Enhanced Cell Apoptosis in Lupus Nephritis
por: Chen, Yi-Cheng, et al.
Publicado: (2020)